|
1
|
Hansson GK and Hermansson A: The immune
system in atherosclerosis. Nat Immunol. 12:204–212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nat Immunol. 473:317–325. 2011.
|
|
3
|
Niessner A and Weyand CM: Dendritic cells
in atherosclerotic disease. Clin Immunol. 134:25–32. 2010.
View Article : Google Scholar :
|
|
4
|
Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee
JK, Sohn SY, Cho Y, Zhang BT and Kim VN: Molecular basis for the
recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell.
125:887–901. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sayed D, Hong C, Chen IY, Lypowy J and
Abdellatif M: MicroRNAs play an essential role in the development
of cardiac hypertrophy. Circ Res. 100:416–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tatsuguchi M, Seok HY, Callis TE, Thomson
JM, Chen JF, Newman M, Rojas M, Hammond SM and Wang DZ: Expression
of microRNAs is dynamically regulated during cardiomyocyte
hypertrophy. J Mol Cell Cardiol. 42:1137–1141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thum T, Galuppo P, Wolf C, Fiedler J,
Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J,
Haverich A, et al: MicroRNAs in the human heart: a clue to fetal
gene reprogramming in heart failure. Circulation. 116:258–267.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Rooij E and Olson EN: microRNAs put
their signatures on the heart. Physiol Genomics. 31:365–366. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Rooij E and Olson EN: MicroRNAs:
powerful new regulators of heart disease and provocative
therapeutic targets. J Clin Invest. 117:2369–2376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Rooij E, Sutherland LB, Liu N,
Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A
signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Busch M and Zernecke A: microRNAs in the
regulation of dendritic cell functions in inflammation and
atherosclerosis. J Mol Med (Berl). 90:877–885. 2012. View Article : Google Scholar
|
|
12
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Connell RM, Rao DS, Chaudhuri AA, Boldin
MP, Taganov KD, Nicoll J, Paquette RL and Baltimore D: Sustained
expression of microRNA-155 in hematopoietic stem cells causes a
myeloproliferative disorder. J Exp Med. 205:585–594. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu F, Weidmer A, Liu CG, Volinia S, Croce
CM and Lieberman PM: Epstein-Barr virus-induced miR-155 attenuates
NF-kappaB signaling and stabilizes latent virus persistence. J
Virol. 82:10436–10443. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shinmei S, Sakamoto N, Goto K, Sentani K,
Anami K, Hayashi T, Teishima J, Matsubara A, Oue N, Kitadai Y and
Yasui W: MicroRNA-155 is a predictive marker for survival in
patients with clear cell renal cell carcinoma. Int J Urol.
20:468–477. 2013. View Article : Google Scholar
|
|
16
|
Sun Y, Wang M, Lin G, Sun S, Li X, Qi J
and Li J: Serum microRNA-155 as a potential biomarker to track
disease in breast cancer. PLoS One. 7:e470032012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nazari-Jahantigh M, Wei Y, Noels H, Akhtar
S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, et
al: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in
macrophages. J Clin Invest. 122:4190–4202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei Y, Zhu M, Corbalán-Campos J, Heyll K,
Weber C and Schober A: Regulation of Csf1r and Bcl6 in macrophages
mediates the stage-specific effects of microRNA-155 on
atherosclerosis. Arterioscler Thromb Vasc Biol. 35:796–803. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu J, Chen T, Yang L, Li Z, Wong MM,
Zheng X, Pan X, Zhang L and Yan H: Regulation of microRNA-155 in
atherosclerotic inflammatory responses by targeting MAP3K10. PLoS
One. 7:e465512012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Donners MM, Wolfs IM, Stöger LJ, van der
Vorst EP, Pöttgens CC, Heymans S, Schroen B, Gijbels MJ and de
Winther MP: Hematopoietic miR155 deficiency enhances
atherosclerosis and decreases plaque stability in hyperlipidemic
mice. PLoS One. 7:e358772012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian FJ, An LN, Wang GK, Zhu JQ, Li Q,
Zhang YY, Zeng A, Zou J, Zhu RF, Han XS, et al: Elevated
microRNA-155 promotes foam cell formation by targeting HBP1 in
atherogenesis. Cardiovasc Res. 103:100–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu GF, Yang LX, Guo RW, Liu H, Shi YK,
Wang H, Ye JS, Yang ZH and Liang X: miR-155 inhibits oxidized
low-density lipoprotein-induced apoptosis of RAW264.7 cells. Mol
Cell Biochem. 382:253–261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang YH, Xia LH, Jin JM, Zong M, Chen M
and Zhang B: Expression level of miR-155 in peripheral blood. Asian
Pac J Trop Med. 8:214–219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen T, Yan H, Li Z, Jing T, Zhu W, Ge J,
Zheng X, Pan X, Yan H and Zhu J: MicroRNA-155 regulates lipid
uptake, adhesion/chemokine marker secretion and SCG2 expression in
oxLDL-stimulated dendritic cells/macrophages. Int J Cardiol.
147:446–447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McCoy CE, Sheedy FJ, Qualls JE, Doyle SL,
Quinn SR, Murray PJ and O'Neill LA: IL-10 inhibits miR-155
induction by toll-like receptors. J Biol Chem. 285:20492–20498.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li P, Grgurevic S, Liu Z, Harris D,
Rozovski U, Calin GA, Keating MJ and Estrov Z: Signal transducer
and activator of transcription-3 induces microRNA-155 expression in
chronic lymphocytic leukemia. PLoS One. 8:e646782013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rodriguez A, Vigorito E, Clare S, Warren
MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska
EA, et al: Requirement of bic/microRNA-155 for normal immune
function. Science. 316:608–611. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Faraoni I, Antonetti FR, Cardone J and
Bonmassar E: miR-155 gene: a typical multifunctional microRNA.
Biochim Biophys Acta. 1792:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
van den Berg A, Kroesen BJ, Kooistra K, de
Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A,
Maggio E and Poppema S: High expression of B-cell receptor
inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes
Chromosomes Cancer. 37:20–28. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martin MM, Buckenberger JA, Jiang J,
Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD and Elton
TS: The human angiotensin II type 1 receptor +1166 A/C polymorphism
attenuates microRNA-155 binding. J Biol Chem. 282:24262–24269.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yin Q, Wang X, McBride J, Fewell C and
Flemington E: B-cell receptor activation induces BIC/miR-155
expression through a conserved AP-1 element. J Biol Chem.
283:2654–2662. 2008. View Article : Google Scholar
|
|
33
|
Lind EF, Millar DG, Dissanayake D, Savage
JC, Grimshaw NK, Kerr WG and Ohashi PS: miR-155 upregulation in
dendritic cells is sufficient to break tolerance in vivo by
negatively regulating SHIP1. J Immunol. 195:4632–4640. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Santiago FS, Lowe HC, Bobryshev YV and
Khachigian LM: Induction of the transcriptional repressor Yin
Yang-1 by vascular cell injury. Autocrine/paracrine role of
endogenous fibroblast growth factor-2. J Biol Chem.
276:41143–41149. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martin-McNulty B, Tham DM, da Cunha V, Ho
JJ, Wilson DW, Rutledge JC, Deng GG, Vergona R, Sullivan ME and
Wang YX: 17 Beta-estradiol attenuates development of angiotensin
II-induced aortic abdominal aneurysm in apolipoprotein E-deficient
mice. Arterioscler Thromb Vasc Biol. 23:1627–1632. 2003. View Article : Google Scholar : PubMed/NCBI
|
